Even when the analysis includes all deaths and all hospitalizations regardless of cause, empagliflozin’s effect on morbidity and mortality remained clinically meaningful and highly significant.
← all excerpts
Effect of Empagliflozin on the Clinical Stability of Patients With Heart Failure and a Reduced Ejection Fraction: The EMPEROR-Reduced Trial.
2
—
—
The sentences
The effect of empagliflozin on first and recurrent hospitalizations for heart failure was consistent in 12 prespecified subgroups, except for a nominally significant treatment-by-race interaction ( Figure II in the Data Supplement ).